Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.

Pharmaceutical Strategies Group (“PSG”), an EPIC company, published its 2025 Trends in Drug Benefit Design Report, delivering critical insights into how payers are navigating a rapidly ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases.

Pharmacy benefit managers, the middlemen between drug manufacturers and insurance providers, would face a range of new requirements under a bill heading to Gov. Kim Reynolds' desk. Supporters say ...

Rising drug prices are hammering patients, employers, and insurers. Is there any end in sight? Soaring demand for high-priced weight loss drugs, known as GLP-1s, has worsened affordability issues ...

Although, PCMA said the governor missed the mark on the value pharmacy benefit managers provide. They argue the core mission of PBMs is to lower prescription drug costs and increase access.

Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily activities by up to 13 months, though their clinical relevance remains ...

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...